Performance of Elucirem in DSC-MRI Perfusion of Brain Gliomas

NCT06057168 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

138

Enrollment

INDUSTRY

Sponsor class

Conditions

Brain Tumor, Primary
Brain Tumor, Recurrent

Interventions

DRUG: Elucirem
DRUG: Dotarem

Sponsor

Guerbet